vTv Therapeutics Inc.
VTVT
$33.15
$0.361.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 36.84M | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 36.84M | -- | -- | -- |
| Cost of Revenue | 8.77M | 8.98M | 3.91M | 7.02M | 4.10M |
| Gross Profit | -8.77M | 27.86M | -3.91M | -7.02M | -4.10M |
| SG&A Expenses | 5.16M | 4.60M | 3.98M | 3.68M | 3.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.93M | 13.58M | 7.89M | 10.70M | 7.72M |
| Operating Income | -13.93M | 23.26M | -7.89M | -10.70M | -7.72M |
| Income Before Tax | -13.05M | 24.13M | -7.14M | -10.35M | -7.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.05M | 24.13M | -7.14M | -10.35M | -7.38M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 0.00 | 1.65M | 1.33M |
| Net Income | -13.05M | 24.13M | -7.14M | -8.70M | -6.05M |
| EBIT | -13.93M | 23.26M | -7.89M | -10.70M | -7.72M |
| EBITDA | -13.93M | 23.26M | -7.88M | -10.70M | -7.72M |
| EPS Basic | -1.05 | 1.94 | -0.58 | -1.08 | -0.92 |
| Normalized Basic EPS | -0.66 | 1.22 | -0.36 | -0.60 | -0.50 |
| EPS Diluted | -1.05 | 1.65 | -0.58 | -1.08 | -0.92 |
| Normalized Diluted EPS | -0.66 | 1.03 | -0.36 | -0.60 | -0.50 |
| Average Basic Shares Outstanding | 12.41M | 12.41M | 12.41M | 8.06M | 6.59M |
| Average Diluted Shares Outstanding | 12.41M | 14.63M | 12.41M | 8.06M | 6.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |